Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage

Author： Laszlo F.A. Varga C. Nakamura S.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.364, Iss.2, 1999-01, pp. : 115-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage

By Topcuogğlu Mehmet Akif Singhal Aneesh B

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 57-65

Informa Healthcare

Access to resources Recommend Favorite

Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

By Macdonald R Loch

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1761-1767

Informa Healthcare

Access to resources Recommend Favorite

Lixivaptan: a novel vasopressin receptor antagonist

By Ku Elaine Nobakht Niloofar Campese Vito M

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 657-662

Informa Healthcare

Access to resources Recommend Favorite

Topical Application of Dexamethasone to Prevent Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage: A Pilot Study

By Fei Luo Golwa Filimon

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 827-832

Adis International

Access to resources Recommend Favorite

Ferrous Chelator 2,2′-Dipyridyl Attenuates Cerebral Vasospasm after Experimental Subarachnoid Haemorrhage in Rabbits

By Yu YY Niu L Gao L Zhang GL Li J Deng JP Qu YZ Zhao ZW Gao GD

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 583-592

Field House Publishing

Access to resources Recommend Favorite